Trial Profile
A real world study evaluating safety and efficacy of mepolizumab in patients with severe eosinophilic asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2019
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2017 New trial record
- 24 May 2017 Results (n=30) presented at the 113th International Conference of the American Thoracic Society